EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

mRNA Vaccine Nanoplatforms and Innate Immunity

Lai Wei, Chunhong Dong iD, Wandi Zhu, Bao-Zhong Wang iD

Viruses · 14.01.2024 · 16 (1) · 120

DOI: 10.3390/v16010120 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 14.01.2024. Verfasst von Lai Wei und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA. Hauptthemen laut MEDLINE: mRNA Vaccines, Pandemics. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, US National Institutes of Health (NIH).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

mRNA-based vaccine technology has been significantly developed and enhanced, particularly highlighted by the authorization of mRNA vaccines for addressing the COVID-19 pandemic. Various biomaterials are developed in nano-scales and applied as mRNA vaccine delivery platforms. However, how these mRNA nanoplatforms influence immune responses has not been thoroughly studied. Hence, we have reviewed the current understanding of various mRNA vaccine platforms. We discussed the possible pathways through which these platforms moderate the host’s innate immunity and contribute to the development of adaptive immunity. We shed light on their development in reducing biotoxicity and enhancing antigen delivery efficiency. Beyond the built-in adjuvanticity of mRNA vaccines, we propose that supplementary adjuvants may be required to fine-tune and precisely control innate immunity and subsequent adaptive immune responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

mRNA VaccinesPandemicsHumansImmunity, InnateAdaptive ImmunityRNA, Messenger

Stichwörter der Autor:innen

adjuvantsinnate immunitylipid nanoparticlesmRNA vaccinepolymer nanoparticles

Substanzen

mRNA VaccinesRNA, Messenger

Autor:innen und Institutionen

  • Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA.

ORCID-Profile: Chunhong Dong, Bao-Zhong Wang

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • US National Institutes of Health (NIH)

Zitieren

APA

Wei, L., Dong, C., Zhu, W., & Wang, B. Z. (2024). mRNA Vaccine Nanoplatforms and Innate Immunity. Viruses, 16(1), 120. https://doi.org/10.3390/v16010120

Vancouver

Wei L, Dong C, Zhu W, Wang BZ. mRNA Vaccine Nanoplatforms and Innate Immunity. Viruses. 2024;16(1):120. doi:10.3390/v16010120

BibTeX
@article{Wei2024,
  author = {Wei, Lai and Dong, Chunhong and Zhu, Wandi and Wang, Bao-Zhong},
  title = {mRNA Vaccine Nanoplatforms and Innate Immunity},
  journal = {Viruses},
  year = {2024},
  volume = {16},
  number = {1},
  pages = {120},
  doi = {10.3390/v16010120}
}
Kostenlos starten →